Table 4: Treatment Effects on JHIC Item Compliance by Functional Categories: Overall and Interacted with Indicators for Private and Unlicensed Health Facilities at Endline

||Infrastructure<br>(1)|Equipment<br>(2)|Supplies<br>(Low cost)<br>(3)|Supplies<br>(Medium<br>cost)<br>(4)|Management<br>(5)|Medical<br>Records<br>(6)|SOPs<br>(7)|
|---|---|---|---|---|---|---|---|
|**Panel A:** _Overall Impact_||||||||
|Treatment|0.063***|0.072***|0.062***|0.086***|0.034***|0.049**|0.035***|
||(0.012)|(0.010)|(0.010)|(0.019)|(0.008)|(0.024)|(0.007)|
||[0.000]|[0.000]|[0.000]|[0.000]|[0.000]|[0.042]|[0.000]|
|Observations<br>|50927|16726|53711|2892|56321|6337|29617|
|R<sup>2</sup>|0.045|0.047|0.017|0.078|0.042|0.096|0.033|
|Control Mean<br>|0.409<br>|0.278<br>|0.383<br>|0.364<br>|0.289<br>|0.467<br>|0.078<br>|
|Impact: _{_%; SD_}_|_{_15%; 0.13_}_|_{_26%; 0.16_}_|_{_16%; 0.13_}_|_{_24%; 0.18_}_|_{_12%; 0.08_}_|_{_10%; 0.10_}_|_{_45%; 0.13_}_|
|**Panel B:** _Interaction with Private_||||||||
|Treatment|0.035**|0.056***|0.036***|0.029|0.024*|0.012|0.030**|
||(0.015)|(0.015)|(0.014)|(0.034)|(0.013)|(0.037)|(0.011)|
||[0.020]|[0.000]|[0.008]|[0.392]|[0.054]|[0.749]|[0.011]|
|Private HF|-0.092***|-0.005|-0.023|-0.217***|-0.128***|0.006|-0.035***|
||(0.014)|(0.013)|(0.015)|(0.037)|(0.013)|(0.042)|(0.011)|
||[0.000]|[0.687]|[0.121]|[0.000]|[0.000]|[0.885]|[0.001]|
|Private HF x T|0.043***|0.025|0.040**|0.092**|0.014|0.064|0.008|
||(0.017)|(0.017)|(0.017)|(0.040)|(0.016)|(0.046)|(0.013)|
||[0.010]|[0.136]|[0.015]|[0.022]|[0.377]|[0.166]|[0.509]|
|Observations|50927|16726|53711|2892|56321|6337|29617|
|R<sup>2</sup>|0.048|0.047|0.017|0.099|0.054|0.098|0.034|
|Control Mean Public<br>|0.481|0.288|0.398|0.499|0.390|0.463|0.106|
|Control Mean Private|0.370|0.272|0.375|0.276|0.236|0.470|0.062|
|Impact Public: _{_%; SD_}_|_{_7%; 0.07_}_|_{_20%; 0.12_}_|_{_9%; 0.07_}_|_{_6%; 0.06_}_|_{_6%; 0.05_}_|_{_3%; 0.02_}_|_{_28%; 0.10_}_|
|Impact Private: _{_%; SD_}_|_{_21%; 0.16_}_|_{_30%; 0.18_}_|_{_20%; 0.16_}_|_{_44%; 0.27_}_|_{_16%; 0.09_}_|_{_16%; 0.15_}_|_{_61%; 0.16_}_|
|Test T + Private x T = 0 (p-value)|0.000|0.000|0.000|0.000|0.000|0.011|0.000|
|**Panel C:** _Interaction with Unlicensed _|_(Private and activ_|_e at endline on_|_ly)_|||||
|Treatment|0.079***|0.100***|0.072***|0.122***|0.048***|0.053|0.047***|
||(0.016)|(0.015)|(0.015)|(0.025)|(0.014)|(0.042)|(0.011)|
||[0.000]|[0.000]|[0.000]|[0.000]|[0.001]|[0.208]|[0.000]|
|Unlicensed HF at Endline|-0.068***|-0.035**|-0.054***|-0.122***|-0.032***|-0.146***|-0.013|
||(0.015)|(0.014)|(0.018)|(0.033)|(0.011)|(0.050)|(0.009)|
||[0.000]|[0.012]|[0.003]|[0.000]|[0.003]|[0.004]|[0.164]|
|Unlicensed HF at Endline x T|-0.016|-0.057***|0.004|0.001|-0.030*|0.035|-0.028**|
||(0.019)|(0.019)|(0.024)|(0.048)|(0.017)|(0.060)|(0.014)|
||[0.400]|[0.003]|[0.883]|[0.976]|[0.084]|[0.557]|[0.039]|
|Observations|33125|10700|33929|1752|36640|3646|18352|
|R<sup>2</sup>|0.052|0.057|0.023|0.098|0.043|0.132|0.034|
|Control Mean Licensed|0.425|0.310|0.402|0.340|0.273|0.560|0.076|
|Control Mean Unlicensed|0.304|0.224|0.332|0.138|0.188|0.318|0.038|
|Impact Licensed: _{_%; SD_}_<br>|_{_19%; 0.16_}_<br>|_{_32%; 0.22_}_<br>|_{_18%; 0.15_}_<br>|_{_36%; 0.26_}_<br>|_{_18%; 0.11_}_<br>|_{_9%; 0.11_}_<br>|_{_61%; 0.18_}_<br>|
|Impact Unlicensed: _{_%; SD_}_|_{_21%; 0.14_}_|_{_19%; 0.10_}_|_{_23%; 0.16_}_|_{_89%; 0.36_}_|_{_10%; 0.05_}_|_{_28%; 0.19_}_|_{_48%; 0.10_}_|
|Test T + Unlicensed x T = 0 (p-value)|0.000|0.001|0.000|0.002|0.034|0.036|0.004|

_Notes_ . Robust standard errors are reported in parentheses and clustered at the market level. P-values are reported in brackets. *** (**) (*) denotes significance at 1% (5%) (10%) level. Regressions include randomization strata controls (by county and market size) and health facility level controls. HF = health facility; JHIC = Joint Health Inspection Checklist.

21